Several members of the British Pharmacological Society have been honoured in the 2021 Queen’s Birthday List for their achievements and contributions to science. We would like to offer our congratulations to the following members.
Steve Rees, the Society’s elected Industry Trustee, and Vice President, Discovery Biology at AstraZeneca, was awarded Order of the British Empire (OBE) for services to UK science and the COVID-19 response.
Professor Sir Martin Landray, Professor of Medicine and Epidemiology, University of Oxford, was awarded a knighthood for services to public health and science. Professor Landray is Co-Chief Investigator for the RECOVERY trial. RECOVERY aims to identify treatments for patients with COVID-19. Professor Landray is a Society Fellow and a keynote speaker for the 19th World Congress of Basic & Clinical Pharmacology 2023 (WCP2023).
Professor Suzanne Cholerton was awarded an OBE for services to higher education during her time at Newcastle University. Professor Cholerton made enormous contributions in her roles from Director of Medical Studies to Pro-Vice Chancellor Education.
The Society would also like to congratulate Professor Sir Andrew Pollard and Professor Dame Sarah Gilbert, both are due to speak at our upcoming events.
Professor Sir Andrew Pollard, Professor of Paediatric Infection and Immunity at the University of Oxford, was awarded a knighthood for services to public health, particularly during the COVID-19 pandemic. Professor Pollard is a keynote speaker at WCP2023.
Professor Dame Sarah Gilbert, Saïd Professorship of Vaccinology at the Jenner Institute and Nuffield Department of Clinical Medicine, was awarded a damehood for services to science and public health in COVID vaccine development. Professor Gilbert is the British Journal of Pharmacology’s plenary speaker at our upcoming Pharmacology 2021 meeting.
I am honoured that my work has been recognised by the award of an OBE for services to science and the COVID-19 response. Throughout my career in the pharmaceutical industry I have had the privilege of working with outstanding colleagues and collaborators to identify and validate new drug targets, leading to new drug discovery projects and ultimately medicines to patients. The last year has seen science performing at its best to protect society during the pandemic. I am proud of the work to establish the Cambridge COVID-19 Test Centre that successfully tested 3.25 million patient samples for the presence of COVID-19 infection. This laboratory was created at a time of crises by outstanding people working collaboratively across industry and academia and delivered both testing capability and innovations to the testing process. I have also had the opportunity to work with the British Pharmacological Society, ELRIG and the Society of Laboratory Automation and Screening in many volunteer roles to foster education and collaboration to create opportunities for technology development and ultimately the delivery of new medicines to patients.
- Steve Rees OBE, elected Industry Trustee of the British Pharmacological Society, and Vice President, Discovery Biology at AstraZeneca.